NC Life Sciences Companies Embrace AI Across Multiple Functions

By Kyle Marshall, NC Biotech

Artificial intelligence is no longer a supporting tool in North Carolina’s life sciences sector—it’s quickly becoming the backbone of innovation across research, development, and manufacturing. From AI-native startups tackling complex challenges like drug toxicity prediction to established companies embedding machine learning into clinical trials and production workflows, the shift is accelerating. Increased NIH funding and a growing number of AI-focused companies signal both momentum and long-term commitment. Across therapeutics, medtech, agtech, and biomanufacturing, organizations are leveraging AI to reduce costs, enhance precision, and speed decision-making. As adoption expands, AI is poised to redefine how therapies are discovered, developed, and delivered.

Dive deeper to see how this transformation is reshaping one of the nation’s leading life sciences hubs.